venBio Select Advisor

Avoro Capital Advisors as of June 30, 2024

Portfolio Holdings for Avoro Capital Advisors

Avoro Capital Advisors holds 41 positions in its portfolio as reported in the June 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
United Therapeutics Corp Common (UTHR) 12.1 $911M 2.9M 318.55
Madrigal Pharmaceuticals Common (MDGL) 7.7 $576M 2.1M 280.16
Ascendis Pharma Sponsored ADR (ASND) 7.6 $572M 4.2M 136.38
Argenx Se Sponsored ADR (ARGX) 7.1 $533M 1.2M 430.04
Sarepta Therapeutics Common (SRPT) 6.3 $474M 3.0M 158.00
Krystal Biotech Common (KRYS) 6.0 $447M 2.4M 183.64
Apellis Pharmaceuticals Common (APLS) 5.7 $426M 11M 38.36
Biomarin Pharmaceutical Common (BMRN) 5.0 $375M 4.6M 82.33
Cerevel Therapeutics Hldng Common (CERE) 4.1 $308M 7.5M 40.89
Spdr Series Trust - S&p Biotech Etf (XBI) 3.7 $281M 3.0M 92.71
Amicus Therapeutics Common (FOLD) 3.6 $272M 27M 9.92
Avidity Biosciences Common (RNA) 3.5 $266M 6.5M 40.85
Arrowhead Pharmaceuticals Common (ARWR) 3.1 $231M 8.9M 25.99
Xenon Pharmaceuticals Common (XENE) 2.9 $221M 5.7M 38.99
Intra-cellular Therapies Common (ITCI) 2.7 $206M 3.0M 68.49
Vera Therapeutics Common (VERA) 2.1 $156M 4.3M 36.18
Moonlake Immunotherapeutics Class A Ord (MLTX) 1.6 $122M 2.8M 43.97
Kymera Therapeutics Common (KYMR) 1.5 $116M 3.9M 29.85
Alnylam Pharmceuticals Common (ALNY) 1.3 $97M 400k 243.00
Iovance Biotherapeutics Common (IOVA) 1.2 $94M 12M 8.02
Soleno Therapeutics Common (SLNO) 1.1 $85M 2.1M 40.80
Merus N V Common (MRUS) 1.1 $80M 1.4M 59.17
Syndax Pharmaceuticals Common (SNDX) 1.1 $80M 3.9M 20.53
Biocryst Pharmaceuticals Common (BCRX) 1.0 $78M 13M 6.18
Kura Oncology Common (KURA) 1.0 $73M 3.5M 20.59
Ocular Therapeutix Common (OCUL) 0.7 $55M 8.1M 6.84
Mannkind Corp Common (MNKD) 0.6 $46M 8.8M 5.22
Vaxcyte Common (PCVX) 0.6 $43M 575k 75.51
Spyre Therapeutics Common (SYRE) 0.6 $43M 1.8M 23.51
Autolus Therapeutics Sponsored ADR (AUTL) 0.6 $43M 12M 3.48
Taysha Gene Therapies Common (TSHA) 0.6 $42M 19M 2.24
Ultragenyx Pharmaceutical Common (RARE) 0.5 $34M 830k 41.10
Verrica Pharmaceuticals Common 0.4 $29M 4.0M 7.29
Tourmaline Bio Common (TRML) 0.4 $29M 2.2M 12.86
Cg Oncology Common (CGON) 0.3 $22M 700k 31.57
Monte Rosa Therapeutics Common (GLUE) 0.2 $17M 4.5M 3.74
Bicycle Therapeutics Sponsored ADR (BCYC) 0.2 $14M 700k 20.24
Aadi Biosciences Common (WHWK) 0.1 $4.2M 2.8M 1.46
Dyne Therapeutics Common (DYN) 0.1 $4.1M 116k 35.29
Adverum Biotechnologies Common (ADVM) 0.0 $2.9M 417k 6.86
Neurogene Common (NGNE) 0.0 $802k 22k 36.39